Your Article Summary
Glaxos Avandia Medicine Doesnt Aid Diabetics Health, Researchers Say
Corporate News Releases - The Healthcare Sales & Marketing Network, 07/18/07
GlaxoSmithKline Plc's diabetes pill Avandia doesn't 'positively influence' the health of diabetics and contributes to weight gain, swelling, heart risks and broken bones, according to a review of 18 studies. Avandia didn't reduce death, stop new health complications or improve diabetics' quality of life, according to the analysis published in the Cochrane Library. The drug also didn't lower blood sugar better than other diabetes pills
| Previous Article | Next Article |
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardinal Health Foundation names finalists in public service announcement contest for prescription drug abuse
Cardinal Health, 07/02/09
PhRMA Statement on Health Care Reform
PhRMA, 06/15/09
Managing the Crisis of Marginalization
PharmExec, 06/09/09
Article Search
Sponsor


See Latest Articles


